Regeneron Pharmaceuticals (REGN) Prepaid Assets (2009 - 2026)

Regeneron Pharmaceuticals' Prepaid Assets history runs 18 years deep, the most recent figure standing at $801.7 million for Q2 2026.

• In Q2 2026, Prepaid Assets rose 39.6% year-over-year to $801.7 million; the TTM figure through Jun 2026 stood at $801.7 million (up 39.6% YoY), while the FY2025 annual figure was $474.8 million, up 35.97% from the prior year.
• Prepaid Assets for Q2 2026 stood at $801.7 million, up from $620.9 million in the prior quarter.
• The five-year high for Prepaid Assets was $801.7 million in Q2 2026, with the low at $349.2 million in Q4 2024.
• The 5-year median for Prepaid Assets is $457.6 million (2022), against an average of $499.7 million.
• The sharpest annual moves came in 2022 and 2023: Prepaid Assets surged 98.92% in 2022, then plunged 37.23% in 2023.
• Regeneron Pharmaceuticals' Prepaid Assets stood at $411.2 million in 2022, then retreated by 5.98% to $386.6 million in 2023, then decreased by 9.67% to $349.2 million in 2024, then jumped by 35.97% to $474.8 million in 2025, then soared by 68.85% to $801.7 million in 2026.
• Business Quant data shows REGN's Prepaid Assets at $801.7 million in Q2 2026, $620.9 million in Q1 2026, and $474.8 million in Q4 2025.